Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses
Open Access
- 12 January 2022
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 96 (1) , e0134321
Abstract
It is generally accepted that an effective HIV-1 vaccine should be able to induce broad-spectrum neutralizing antibodies. Since most of these antibodies require long periods of somatic maturationin vivo, several groups are developing immunogens, based on the HIV envelope protein, that require complex and lengthy immunization protocols that would be difficult to implement in the general population.Keywords
Funding Information
- IDIBAPS (80:20 Research Grant)
- European Union Horizon 2020 (681137-EAVI2020)
- Fondation Dormeur, Vaduz
- Ministerio de Economia, Industria y Competitividad (PI17CIII/00049)
- Ministerio de Ciencia, Innovación y Universidades (RD16CIII/0002/0001)
- Ministerio de Ciencia, Innovación y Universidades (RD16CIII/0002/0005)
- Ministerio de Ciencia, Innovación y Universidades (RD16/0025/0041)
- Consejo Nacional de Innovación, Ciencia y Tecnología
- Ministerio de Ciencia e Innovación (PI20CIII/00039)
- HHS | National Institutes of Health (P01-AI131568)
This publication has 65 references indexed in Scilit:
- HIV-1 Virus-Like Particles Bearing Pure Env Trimers Expose Neutralizing Epitopes but Occlude Nonneutralizing EpitopesJournal of Virology, 2012
- Broadly Cross-Neutralizing Antibodies in HIV-1 Patients with Undetectable ViremiaJournal of Virology, 2011
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1Science, 2010
- Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2009
- Frequency and Phenotype of Human Immunodeficiency Virus Envelope-Specific B Cells from Patients with Broadly Cross-Neutralizing AntibodiesJournal of Virology, 2009
- Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and CJournal of Virology, 2008
- N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virusVirology, 2007
- A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120Virology, 2007
- Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected DonorsJournal of Virology, 2007
- Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5αProceedings of the National Academy of Sciences, 2006